US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
カナダ
TSXV
Stakeholder Gold Corp (SRC) 銘柄情報

Stakeholder Gold Corp (SRC)

1.65

0.00

(0.00%)

終了 6月11日 5:00AM

Stakeholder Gold Corp (SRC) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

1.65

( - )

買値

1.60

売値

1.65

出来高

-

0.00 日の範囲 0.00

0.62 52 週間の範囲 1.75

時価総額

前日終値

1.65

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

$ 12,291

発行済株式数

24,853,912

配当利回り

PER

-13.61

1 株当たり利益 (EPS)

-0.12

歳入

1.64M

純利益

-2.62M

Stakeholder Gold Corp., a mineral exploration company, engages in the acquisition, exploration, and development of mineral resource properties in North America. It primarily explores for precious and base metal deposits. The company holds a 100% interest in the Ballarat gold project that consists of... Stakeholder Gold Corp., a mineral exploration company, engages in the acquisition, exploration, and development of mineral resource properties in North America. It primarily explores for precious and base metal deposits. The company holds a 100% interest in the Ballarat gold project that consists of 940 claims covering an area of 19,006 hectares located in the White Gold District of the Yukon Territory, Canada. It also owns and operates a quartzite quarry in Minas Gerais, Brazil. Stakeholder Gold Corp. was incorporated in 2011 and is headquartered in Toronto, Canada. 詳細を表示

セクター

Materials

業界

Mining

ウェブサイト

www.stakeholdergold.com

本社

Toronto, Canada

設立

2026

Stakeholder Gold Corp is listed in the Materials sector of the トロントベンチャー取引所 with ticker SRC. The last closing price for Stakeholder Gold was $1.65. Over the last year, Stakeholder Gold shares have traded in a share price range of $ 0.62 to $ 1.75.

Stakeholder Gold currently has 24,853,912 shares in issue. The market capitalisation of Stakeholder Gold is $41.01 million. Stakeholder Gold has a price to earnings ratio (PE ratio) of -13.61.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.05	-2.94117647059	1.7	1.7	1.6	13724	1.66623483	CS
4	0.27	19.5652173913	1.38	1.75	1.26	18725	1.51776092	CS
12	0.69	71.875	0.96	1.75	0.96	11323	1.41201991	CS
26	0.84	103.703703704	0.81	1.75	0.74	12604	1.2006414	CS
52	0.9	120	0.75	1.75	0.62	9943	1.04362263	CS
156	1	153.846153846	0.65	1.75	0.55	5997	0.97210577	CS
260	0.87	111.538461538	0.78	1.75	0.33	5810	0.91502641	CS

SRC - Frequently Asked Questions (FAQ)

What is the current Stakeholder Gold Corp share price?

The current share price of Stakeholder Gold Corp is $ 1.65

How many Stakeholder Gold Corp shares are in issue?

Stakeholder Gold Corp has 24,853,912 shares in issue

What is the market cap of Stakeholder Gold Corp?

The market capitalisation of Stakeholder Gold Corp is CAD 41.01M

What is the 1 year trading range for Stakeholder Gold Corp share price?

Stakeholder Gold Corp has traded in the range of $ 0.62 to $ 1.75 during the past year

What is the PE ratio of Stakeholder Gold Corp?

The price to earnings ratio of Stakeholder Gold Corp is -13.61

What is the cash to sales ratio of Stakeholder Gold Corp?

The cash to sales ratio of Stakeholder Gold Corp is 25.82

What is the registered address of Stakeholder Gold Corp?

The registered address for Stakeholder Gold Corp is 607 - 130 Queens Quay E., Toronto, Ontario, M5A 3Y5

What is the Stakeholder Gold Corp website address?

The website address for Stakeholder Gold Corp is www.stakeholdergold.com

Which industry sector does Stakeholder Gold Corp operate in?

Stakeholder Gold Corp operates in the Mining sector

fink

I’m keeping my focus on Argentina Gold mines. Newmont, but specifically FSM due to the price drop. I think South America will lead the world. Less drama too.

I can’t lose my grip on my LNG to load the boat. Gold takes time.

Trooperstocks

Trooperstocks 16秒前

$MAJI Acquisitions bring immediate $135,000 in monthly recurring revenue prior to near-term scaling initiatives; Transaction structured as non-dilutive to MAJI shareholders. https://seekingalpha.com/pr/20537528-nextel-medical-corp-executes-definitive-purchase-agreements-to-acquire-jumpstartrx-and

Trooperstocks

Trooperstocks 21秒前

$MAJI Acquisitions bring immediate $135,000 in monthly recurring revenue prior to near-term scaling initiatives; Transaction structured as non-dilutive to MAJI shareholders. https://seekingalpha.com/pr/20537528-nextel-medical-corp-executes-definitive-purchase-agreements-to-acquire-jumpstartrx-and

AveragePenny

AveragePenny 38秒前

PTOP Secures Largest Enterprise Opportunity in Company History With BostonApartments.com(R) - Here is How It Will Operate

https://www.accessnewswire.com/newsroom/en/computers-technology-and-internet/ptop-secures-largest-enterprise-opportunity-in-company-history-wi-1174872

Sammy boy

Sammy boy 42秒前

Every time Trump mentions the evaluation now we drop, very similar to Pulte’s TV appearance’s.

Getting crazier by the day !

Trooperstocks

Trooperstocks 45秒前

$BURU NUBURU Files Golden Power Notification for Majority Acquisition of Tekne, Launching Formal Review by the Italian Government

Golden Power Filing Initiates Review of NUBURU’s Planned Majority Acquisition of Tekne, Supporting Approximately US$459 Million of Pro Rata Exposure to Tek

Trooperstocks

Trooperstocks 50秒前

$BURU NUBURU Files Golden Power Notification for Majority Acquisition of Tekne, Launching Formal Review by the Italian Government

Golden Power Filing Initiates Review of NUBURU’s Planned Majority Acquisition of Tekne, Supporting Approximately US$459 Million of Pro Rata Exposure to Tek

Lite

Wouldn’t re-listing the GSEs greatly enhance transparency of share trading? Why does this Administration not work towards transparency?

EnchantedPirate5

EnchantedPirate5 2分前

agq
buying AGQ on the open.

DOGONE

Good interview. https://podcasts.apple.com/us/podcast/interview-on-amfn-with-executive-chairman-of/id1459370287?i=1000771261150

pennybiteme

pennybiteme 3分前

I was there but you were not just saying.

getmoreshares

getmoreshares 3分前

🌐UNCHANGED OUTSTANDING SHARES 6/10/26

Outstanding Shares 160,236,914 03/11/2026
Restricted 101,420 03/11/2026
Unrestricted 160,135,494 03/11/2026
Held at DTC 160,135,494 03/11/2026
Authorized Share 500,000,000 03/11/2026

docj

CytoDyn Announces First Patient Dosed in Phase 2a Study in Collaboration with Weill Cornell Medicine Evaluating Leronlimab in Alzheimer’s Disease
Download as PDFJune 11, 2026 8:30am EDT
Phase 2a study will evaluate the safety and biological activity of leronlimab in patients over the

big bopper1

big bopper1 3分前

cydy with cornell uniersity will use our drug to do phase 2 study on alzheimer disease.

prototype_101

prototype_101 4分前

LWLG Polymers will solve NVIDIA's MRR (micro-ring resonator modulators) issues!!

Reducing Power Consumption and the Need for Heater ICs: NVIDIA's MRR technology, while highly compact, is susceptible to thermal drift. This means that as the temperature changes, the resonant frequency o

DeadCellShadix

DeadCellShadix 4分前

PPCB Buyback News:

Propanc Biopharma, Inc. (NASDAQ:PPCB) ("Propanc" or the "Company"), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including recurrent and metastatic cancer, today announced it has approved a share repurchase program authori

AlwaysRed

AlwaysRed 4分前

They certainly have been pounding the price the last 4 days:

https://www.cmegroup.com/markets/metals/precious/silver.volume.html

Griff35

Griff35 5分前

getmoreshares

getmoreshares 5分前

had the same downgrade happen to a different position- OTC error.

CatfishHunter

CatfishHunter 5分前

https://x.com/vivosincusa/status/2065050253129331078?s=46&t=MFPDnhLdbuc8M9UmbDfCTw

TheRealSarsoor

TheRealSarsoor 5分前

https://www.linkedin.com/posts/diesel-marketing_investor-presentation-activity-7470787948720869377-PtAR?utm_source=share&utm_medium=member_android&rcm=ACoAAAFYb90BO4fY8BCiB31JXid7ZGW_VhVEiac
Sparc and $HGRAF is official. Putting us in there next to some big names.

mike_dotcom

mike_dotcom 5分前

Another new 52 week low coming? It seems inevitable.

fricassee

fricassee 6分前

Where else can a revolutionary new material go but up?

axelvento

axelvento 6分前

Immuneering Announces First Patient Dosed in Pivotal Phase 3 MAPKeeper 301 Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer

https://ir.immuneering.com/news-releases/news-release-details/immuneering-announces-first-patient-dosed-pivotal-phase-3

trader_ron

trader_ron 6分前

$ARTM News- American Nortel Provides India Operations Update: Technology Infrastructure and Data Systems Positioned to Support Continued Sales Growth
https://www.otcmarkets.com/stock/ARTM/news/American-Nortel-Provides-India-Operations-Update-Technology-Infrastructure-and-Data-Systems-Position

Stakeholder Gold

United Utilities Water F...

Innovator Premium Income...

Goldman Sachs Marketbeta...

Petro Matad (PK)

Essential Properties Rea...

Amundi EUR Corporate Bon...

Unity Wealth Partners Dy...

SSGA SPDR ETFs Europe II... (ID)

VanEck ETF Trust VanEck ...

Intergrated Media Techno...

Renaissance Us Growth Invst

Empr Dis Y Com N B Adr20/

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。